Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Conditions
Non-Arteritic Anterior Ischemic Optic Neuropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Neuro Eye Orbit Institute, Los Angeles, California, United States
David Geffen School of Medicine at UCLA - Ophthalmology, Los Angeles, California, United States
California Orbital Consultants, Newport Beach, California, United States
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida, United States
Sarasota Retina Institute - Research, Sarasota, Florida, United States
Northwestern University - Ophthalmology, Chicago, Illinois, United States
University of Illinois at Chicago Eye and Ear Infirmary - Ophthalmology, Chicago, Illinois, United States
Univ. Of Kentucky Clinic Dept of Ophthalmology & Vision Science, Lexington, Kentucky, United States
The Johns Hopkins Hospital (JHH), Baltimore, Maryland, United States
Tufts Medical Center - Neurology, Boston, Massachusetts, United States
University of Michigan Health - Kellogg Eye Center, Ann Arbor, Michigan, United States
Trinity Health Grand Rapids, Grand Rapids, Michigan, United States
University of Minnesota, Dept of Ophthalmology, Minneapolis, Minnesota, United States
Mayo Clinic - Department of Ophthalmology, Rochester, Minnesota, United States
University of Pennsylvania - Ophthalmology, Philadelphia, Pennsylvania, United States
Retina Consultants of South Carolina, Charleston Neuroscience Institute- West Ashley (RCA), Charleston, South Carolina, United States
Neuro Eye Clinical Trials, Houston, Texas, United States